Effects of percutaneous Neuromuscular Electrical Stimulation (NMES) application to the Quadriceps muscle on vascular viability of the foot in critically ill patients undergoing Extra Corporeal Membrane Oxygenation (ECMO) via femoral cannulation

Paul McCormack0 个研究点目标入组 4 人开始时间: 2016年2月11日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•The study participants will be any patient undergoing ECMO via femoral cannulation in the ICU of The Prince Charles Hospital who would normally receive muscle stimulation as part of their standard physiotherapy care and who do not meet any of the exclusion criteria.

•Patients for whom consent was unable to be obtained
•Male or female < 18 years old
•Inability to independently transfer from bed to chair at baseline before hospital
•Known primary systemic neuromuscular disease at ICU admission
•Known intracranial process associated with localised weakness e.g. cerebrovascular
•accident (CVA) at ICU admission
•End-stage malignancy
•Diseases with systemic vascular involvement
•Bone fractures or skin lesions / open wounds on the area to be treated
•Heavy ischemia of the area to be treated
•Patients with permanent pacemaker (PPM) / implantable cardioverter-defibrillator (ICD)
•Brain death
•Allergic reaction to the electrodes
•Significant lower limbs oedema
•Obesity (Body Mass Index > 35kg/m2)
•Cardiovascular instability as determined clinically by the treating therapist or medical
•If the patient is receiving neuromuscular blockers
•If the patient displayed clinical signs of treatment intolerance. For sedated and
•intubated patients; the level of tolerance will be estimated by assessing signs of distress
•(e.g. significant heart rate (HR) and blood pressure (BP) alterations and/or presence of
•grimacing) as well as regular skin checks

发起方

Paul McCormack